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Abstract: Human embryonic stem cells (hESCs) and reprogrammed human induced pluripotent stem cells (hiPSCs) proliferate
indefinitely in the undifferentiated state (self-renewal) and differentiate into the three germ layers (and ultimately into all cell types)
(pluripotency). Branching in the N-glycan core of hESCs/hiPSCs is limited. hESCs/hiPSCs have high mannose-type and biantennary
complex-type core structures, indicating immature stages of N-glycoproteins. The two branches on the core consist of type 2
N-acetyllactosamine (LacNAc), completed mainly with α 2,6-linked sialic acid. Complex terminal fucosylation, particularly α 1,2-linked
fucosylation, is another characteristic N-glycosylation feature of hESCs/hiPSCs. All of these structural features are probably associated
with the pluripotency of hESCs/hiPSCs. In differentiated cells, two-, three-, and four-branched N-glycan core structures are seen and
N-acetylhexosamine compositions increase in the branches. The elongation and size of the branches in the N-glycan cores increase by
the addition of poly-LacNAc chains and are the typical features during differentiation. As α 1,2-linked terminal fucosylation disappears,
α 1,6-linked core fucosylation increases. It is necessary to know the pluripotency-associated glycans in order to identify and isolate the
pluripotent cells from heterogeneous populations containing differentiated cells.
Key words: Human embryonic stem cell N-glycans, N-glycan core branching, pluripotency, differentiation

1. Introduction
The glycan parts of glycoconjugates and oligosaccharide
chains are intricate information-carrying or informationstoring biopolymers (André et al., 2015; Hu et al., 2015).
They encode extremely rich information in the sugar code,
conveyed via noncovalent hydrogen bonds (Cocinero and
Çarçabal, 2015; Maverakis et al., 2015). Our knowledge
about sugar codes or sugar-based molecular information
systems is much less than our knowledge about DNAprotein-based information systems (Gabius et al., 2002;
Miron and Petitjean, 2015). Free or membrane-associated
glycan binding proteins (GBPs) (lectins, galectins,
selectins, siglecs, mannose-binding proteins and receptors,
antibodies, and glycosylation enzymes) recognize
and interact with certain oligosaccharide motifs of
glycoconjugates (Cummings and Pierce, 2014). In this way,
GBPs play critical roles in deciphering stored information
in sugar codes and translating it into biological responses
(Gabius, 2000; Bernardi and Cheshev, 2008; Kaltner and
Gabius, 2012; Murphy et al., 2013). The exquisite binding
specificities of GBPs determine the composition, sequence,
and linkage of glycan structures (Smith and Cummings,
2013). Immunohistochemical labeling results indicate that
GBPs are mainly distributed in the cytoplasmic membrane,
* Correspondence: sabire.karacali@ege.edu.tr
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the perinuclear region of the cytoplasm, and the Golgi
area (Zhong et al., 2015). Through this intracellular
distribution, GBPs regulate a number of vital processes
in which glycan recognition and adhesion interactions
occur. For instance, N-glycoprotein processing-related
events such as protein folding (Bieberich, 2014; Kaszuba et
al., 2015), protein sorting (Liang et al., 2014), and protein
degradation (Quan et al., 2008; Słomińska-Wojewódzka
and Sandvig, 2015) are performed in these regions using
the recognition interactions of GBPs (lectins) through
related glycan codes or signals. The sugar code recognition
specificity of GBPs can also potentially help determine the
stem cell glycophenotype.
Stem cells are undifferentiated cells with high capacity
for self-renewal and pluripotency. Their self-renewal
property allows embryonic stem cells to proliferate
indefinitely in their undifferentiated state, whereas their
pluripotency indicates their differentiation capacity into
the three germ layers, the endoderm, mesoderm, and
ectoderm, and into all cell types of the adult body (Kraushaar
et al., 2013). Depending on their origin and differentiation
potential, two types of stem cells are distinguished in
humans: human embryonic stem cells (hESCs) and
human somatic or induced pluripotent stem cells (hiPSCs)
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(Nakamura, 2008). hiPSCs are reprogrammed somatic
cells for the pluripotent state via the introduction of
certain transcription factors through cell reprogramming
technology (Takahashi et al., 2007; Alisson-Silva et al.,
2014). hESCs and hiPSCs are attractive sources for cellreplacement therapies. Unfortunately, the tumorigenic
propensity (Itskovitz-Eldor, 2011) of stem cells is a major
obstacle in clinical applications. A new surface marker,
stage-specific embryonic antigen-5 (SSEA-5), that is highly
and specifically expressed on H type-1 glycans of hiPSCs
(Tang et al., 2011) was recently determined. An antibody,
namely anti-SSEA-5, recognizes this highly specific surface
marker on undifferentiated hiPSCs in cell culture; when
applied to incompletely differentiated hESC cultures prior
to cell transplantation, the risk of teratoma formation is
removed through the immunodepletion of SSEA-5 and
two additional markers (Tang et al., 2011). It is clear
that specific markers are required for the discrimination
(Rosu-Myles et al., 2013), isolation (Oliveira and BarretoFilho, 2015), enrichment (Nakatsu and Deng, 2013), and
elimination of tumor initiating cells (Tang et al., 2011) for
the effective utilization of stem cells. Glycans are useful
tools for this purpose (Lanctot et al., 2007; Yanagisawa,
2011). Cell surface glycans are part of glycoconjugates
(glycoprotein, proteoglycans, glycosphingolipids, and
glycophosphatidylinositol anchors) and are the most
appropriate markers to discriminate stem cells from
nonstem cells; moreover, they are also probably associated
with self-renewal (Nakamura, 2008; Higashi et al., 2014;
Pulsipher et al., 2015).
Several changes on the surface glycosylation pattern
occur during differentiation of ESCs (Draper et al.,
2002; Wearne et al., 2006; Satomaa et al., 2009; Dodla et
al., 2011; Wang et al., 2011). The altered glycosylation
pattern disrupts previous cellular interactions and
initiates new interactions between stem cells and their
microenvironments. Characteristic surface glycosylation
patterns of differentiated cells, glycotypes, provide
a molecular signature and serve to discriminate the
differentiated cells from each other even during the
differentiation stages (Varki et al., 2011; Dodla et al., 2012;
Nairn et al., 2012). Some glycan modifications affect the
fate of ESCs. Specific glycans cause ESCs to undergo an
accelerated exit from self-renewal and differentiate into
neuronal cell types (Pulsipher et al., 2015).
There are several methods available to determine the
altering glycophenotype of specific glycan structures in
stem cells during differentiation (Pulsipher et al., 2015).
Previous studies on glycosylation pattern characterization
of stem cell surfaces were conducted with labeled lectin
applications on glycosidase digested or nondigested
cells, using microscopic methods (Venable et al., 2005;
Wearne et al., 2006, 2008). Useful impressions of mainly
terminal and some internal monosaccharide residues of

oligosaccharide chains were obtained from these studies.
Advances in analytical technology, including nuclear
magnetic resonance (NMR) and mass spectrometry, have
provided additional structural information about stem
cell glycosylation (Satomaa et al., 2009). Newly developed
microarray technology has also been used to analyze the
glycans of stem cells (Tateno et al., 2011; Toyoda et al.,
2011).
The current review focused on the cell surface N-glycan
features of hESCs associated with pluripotency and
differentiation. Since glycan molecules are candidates for
sensitive markers, it is necessary to get more information
about the stem cell-associated glycans for quality control
in cell-based therapy.
2. Sequential multibranching on the common N-glycan
core structure
N-glycans are branched chains. Sugar residues are
attached to each other by α and β glycosidic linkages.
They are generated from a common precursor through a
common pathway, by sequential actions of glycosidases
and glycosyltransferases (Figure 1).
The common precursor of N-glycans, consisting of 14
glycan units (2 N-acetylglucosamine (GlcNAc) units, 9
mannose units, and 3 glucose (Glc) units), is formed at the
initial synthesis stage of all N-linked glycoproteins (Taylor
and Drickamer, 2011; Varki et al., 2011; Bieberich, 2014).
After transferring the precursor to the growing peptide,
maturation reactions of the glycans start in the lumen of the
rough endoplasmic reticulum and continue in the Golgi
compartments. Glycosidases and glycosyltransferases
successively modify the structure of the precursor. The
differential actions of these enzymes cause the formation
of a high mannose, hybrid, and complex types of N-linked
oligosaccharides (Figure 1). All of these types have a
common core structure consisting of 3 mannose residues
and 2 GlcNAc residues. Two of the mannose residues
are attached to the first mannose residue by 2 different
linkages (α 1,6 and α 1,3), forming the initiation of 2 basic
arms on the common core structure.
Specific N-acetylglucosaminyltransferases (GlcNAcTs, GnTs) (productions of MGAT genes) are responsible
for the addition of new branches. In vertebrates, 7 different
GnTs, indicated as GnT-I, -II, -III, -IV, -V, -VI and IX, and
a fucosyltransferase (FUT8) have been determined to be
involved in the initiation of branching in the complex
N-glycan core structure (Taniguchi and Korekane, 2011;
Takamatsu et al., 2013). GnTs catalyze the transfer of GlcNAc
sugar from the active donor, uridine diphosphate GlcNAc,
to specific positions on the core mannoses of N-glycans via
a specific glycosidic linkage. Three, four, or more branches
can be initiated by the activity of a specific GnT on the core
structure (Chen et al., 2009).
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Figure 1. Precursor and basic types of N-glycans. The common core structure is shaded.

According to the sequential activity rules established by
Brockhausen et al. (1988) for the GnTs, GnT-I and GnT-II
are involved in initiating the synthesis of various branches
of complex N-glycans. GnT-I acts before all the other GnTs
and is required for the conversion of the high mannose
type (with 5 mannose residues) to the hybrid and complex
types (with 3 mannose residues) of N-glycans (Yip et al.,
1997; Chen et al., 2002; Taniguchi and Korekane, 2011).
It catalyzes the β 1,2 glycosidic linkage by transferring
GlcNAc sugar to the mannose residue on the α 1-3 arm of
the core structure. The α mannosidase II recognizes this
structure, removes the 2 mannose residues from the α 1,6
arm, and a substrate for the GnT-II and GnT-III enzymes
is formed.
GnT-II controls the conversion of hybrid-type to
complex-type structures (D’Agostaro et al., 1995; Ye and
Marth, 2004). GnT-II activity is a prerequisite (Zhang et
al., 2000) for the GnT-IV, GnT-V, and GnT-IX activities,
which are responsible for synthesis of the other branches
on the common N-glycan core and are important for the
conversion to cancer. GnT-II catalyzes the β 1,2 glycosidic
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linkage by adding a GlcNAc to the α 1,6 arm on the core; a
2-branched (biantennary) core structure is formed.
GnT-III catalyzes the formation of the β 1,4 glycosidic
linkage by transferring a bisecting GlcNAc to the first
mannose residue on the core (Figure 2). Various hybrid
and complex N-glycans contain the bisecting GlcNAc.
The presence of a bisecting GlcNAc prevents the catalytic
activity of GnT-II, GnT-IV, GnT-V, and FUT 8 enzymes,
which are responsible for branching of the core structure in
vitro (Brockhausen et al., 1988; Isaji et al., 2010; Taniguchi
and Korekane, 2011; Miwa et al., 2012; Xu et al., 2012).
3.
Characteristic
N-glycan
structure-related
pluripotency in hESCs/hiPSCs
A number of pluripotency biomarkers are currently used to
characterize hESCs and hiPSCs. Stage-specific embryonic
antigens SSEA-3 and SSEA-4 are known to be pluripotent
glycosphingolipid glycan markers of hESCs and hiPSCs
(Lanctot et al., 2007; Liang et al., 2010; Yanagisawa,
2010; Fujitani et al., 2013). A new and highly expressed
surface marker, SSEA-5, was identified on the surface of
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Figure 2. Initial branching on the common core structure of N-glycans, modified from Taniguchi and Korekane (2011) with
permission.

human pluripotent stem cells (Tang et al., 2011). Tumorrejection antigens Tra-1-60 and Tra-1-81 are widely used
to characterize the hESCs (Wright and Andrews, 2009).
They recognize the glycans specifically expressed on the
type 1 lactosamine (Galβ1-3GlcNAc) structure (Fujitani et
al., 2013).
In comparison with glycomic profiles, a lot of new
and important information has been obtained using more
sensitive analytical techniques.

High mannose-type and biantennary (fucosylated
and sialylated) complex-type core structures are the
major pluripotency-specific N-glycosylation features
(Figure 3). High mannose-type N-glycan core structures
include more than 5 mannose residues determined with
matrix-assisted laser desorption/ionization time-offlight (MALDI-TOF) mass spectrometry (MS) and NMR
spectroscopy (Satomaa et al., 2009). Even on the isolated
cell membranes from hESCs, 9 mannose residues with
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Figure 3. Pluripotency-relevant N-glycan features in hESCs.

intact terminal glucose residue were found using flow
cytometry and immunocytochemistry (An et al., 2012).
The results obtained from fluorescein-labeled lectin
staining (Wearne et al., 2006), flow cytometry, and
immunohistochemistry (Venable et al., 2005; Dodla et
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al., 2011) showed that hESCs expressed high percentages
of high mannose glycans. In addition, upon induction of
pluripotency, a significant increase occurred in the high
mannose-type N-glycans, indicating the immature stage
of N-glycoproteins (Hasehira et al., 2012; Hamouda et al.,
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2014). High mannose-type N-glycans were also associated
with the mesenchymal stem cell characteristic feature for
human mesenchymal stem cells in a couple of studies
(Hemmoranta et al., 2007; Heiskanen et al., 2009). On the
contrary, in another study high mannose-type N-glycans
were decreased in hESC and iPSC mixture (Tateno et al.,
2011).
Biantennary complex-type core structures bear 2
LacNAc branches that are terminated with α 2,6 and
α 2,3-linked sialic acids. A fucose residue is located
subterminal to sialic acid. The MALDI-TOF MS spectrum
(Satomaa et al., 2009), labeled lectins (Wearne et al., 2006;
Dodla et al., 2011), and lectin microarray (Tateno et al., 2011)
indicated the presence of these sugars. Since desialylated
and defucosylated N-glycans of hESCs were sensitive to β
1,4- galactosidase but not to β 1,3 galactosidase digestion,
it was suggested that the N-glycan antennae consist of
type 2 N-acetyllactosamine (LacNAc, Gal β1-4 GlcNAc-)
chains (Satomaa et al., 2009). However, the type 1 LacNAc
(Galβ1-3GlcNAc) structure was suggested in particular as
one of the characteristic feature of hiPSCs (Tateno et al.,
2011; Hasehira et al., 2012). In addition to the N-glycans
of hESCs carrying type 2 LacNAc (Satomaa et al., 2009),
various type 1 LacNAc structures were also typical features
of O-glycans and glycosphingolipids of pluripotent human
cells (Natunen et al., 2011). This is possible by the activity
of 3β-galactosyltransferase, which is also responsible for
the elongation of oligosaccharide chains on both mucins
and glycolipids (Sheares et al., 1982, 1983).
Complex terminal fucosylation is the other
characteristic N-glycosylation feature of hESCs (Satomaa
et al., 2009; Tateno et al, 2011; Hasehira et al., 2012). One
terminal of the branches bears an α 1,2-linked fucose
residue (Fuc α 1-2 Gal β 1-4 GlcNAc); the other terminal
bears an α 1,3- or α 1,4-linked fucose residue, producing an
Lex structure (Gal β 1-4 (Fuc α 1-3) GlcNAc) (Satomaa et al.,
2009). A recombinant peptide, rBC2LCN, recognizes and
binds specifically to Fucα1-2Galβ1-3GlcNAc(GalNAc)containing glycans. It has been suggested that it is an
alternative to conventional pluripotent marker antibodies
(Onuma et al., 2013). A core α 1,6-linked fucose residue,
linked to the GlcNAc residue (which is directly attached
to the asparagine residue of the protein), is found on the
biantennary complex-type core structure. This type of
α 1,6-linked fucosylation is the most abundant fucose
linkage in hESC N-glycans (Satomaa et al., 2009).
The α 2,3- and α 2,6-linked sialic acids, with the α
2,6-linked one higher than the former, were seen on
N-glycans of hESCs (Satomaa et al., 2009).
The linkage type of the sialic acid on N-linked glycans
was dramatically changed from α 2,3 to α 2,6 upon
induction of pluripotency (Tateno et al., 2011; Hasehira et
al., 2012). A linkage shift may affect the biological functions

of endogenous lectins. The binding activity of galectins is
greatly diminished when LacNAc chains are capped with
α 2,6-linked sialic acids (Iwaki et al., 2011; Hirabayashi
et al., 2002). In summary, the high mannose-type and
biantennary complex-type N-glycan core structures, type2 LacNAc, terminal α 1,2 fucosylation, and α 2,6-linked
sialic acids are all characteristic pluripotency features of
the N-glycans in hESCs.
4. Changes in N-glycans during hESC differentiation
Characteristic N-glycan profiles of hESCs undergo
some major changes during cell differentiation. Glycan
structures on undifferentiated cells disappear and a new
glycan profile occurs on embryoid bodies and on further
differentiated cells. Comparison with fluorescein-labeled
lectin images on embryoid bodies generated from BG01
hESCs (Wearne et al., 2006) and MALDI-TOF MS and
proton NMR spectroscopic analyses on embryoid bodies
formed from four Finish hESC lines (Satomaa et al., 2009)
provided important information about glycan alteration
during differentiation. Lectin microarrays obtained from
four different somatic cell line-generating hiPSCs and
from a number of hiPSCs clearly revealed these alterations
(Tateno et al., 2011).
The low mannose-type, the hybrid-type, and the
complex-type N-glycan core structures (Figure 2) were
found more abundantly in differentiated cells (Satomaa et al.,
2009). One of the early signs for differentiation-associated
N-glycan changes is the increase in branching on the core
structure of N-glycans. N-acetylglucosaminyltransferaseIII (production of the MGAT gene) catalyzes the β 1,4
glycosidic linkage formation by transferring a bisecting
GlcNAc to the first mannose residue on the core (Figure
2). N-glycan signals associated with differentiated
cells (Satomaa et al., 2009; Tateno et al., 2011) and the
distribution of PHA-E lectin ligands (Venable et al.,
2005; Wearne et al., 2006) indicate this modification.
The bisecting GlcNAc was found on various hybrid and
complex N-glycans of healthy differentiated cells. The
presence of bisecting GlcNAc prevents the subsequent
processing and elongation of N-glycans, inhibiting the
catalytic activity of the enzymes that are responsible for
branching of the core structure (Brockhausen et al., 1988;
Taniguchi and Korekane, 2011).
The other major differentiation stage-associated
N-glycan signals are related to the multifucosylation of
sialylated N-glycans, which are gradually decreased during
hESC differentiation (Satomaa et al., 2009), where no α
1,2-linked terminal fucosylation appears (Wearne et al.,
2006). Instead of terminal fucosylation, the α 1,6-linked
core fucosylation increases (Tateno et al., 2011). PHA-L
lectin signs were low in hiPSCs (Tateno et al., 2011), but
they were significantly higher in differentiated human
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neural progenitor and human mesenchymal progenitor
cells (Dodla et al., 2011). This lectin is specific for the
N-linked tri- and tetraantennary chains with Gal β1-4
GlcNAc on the β1-6 mannose branch.
In a transition embryoid body, the low mannose-type
and the hybrid-type N-glycans were the characteristic
structures (Satomaa et al., 2009). The hybrid-type
N-glycans bear mainly the core fucose and their branches
are terminated with both α 2,6- and α 2,3-linked sialic
acids.
N-acetylhexosamine compositions drastically
increase during differentiation of hESCs into the embryoid
body. The signal intensity of N-acetylhexosamine was
found to be 3% for hESCs. An increase of 14% for the
embryoid body and 22% for further differentiated cells
was observed (Satomaa et al., 2009). The number of
poly-N-acetyllactosaminyl chains on the core branches

was associated with differentiated cells (Karaçalı et al.,
2014). An increase in poly-N-acetyllactosaminyl repeats
occurred in embryonic stem cells during differentiation
(Wearne et al., 2006).
5. Conclusion
Extensive efforts have been made to understand
the biological significance of the glycan parts of
glycoconjugates. Pluripotent hESC and hiPSC N-glycans
bear mainly high mannose-type and biantennary complextype core structures. The α 1,2/1,3-linked terminal
fucosylations and the α 2,6-linked sialic acids are the other
characteristic features of pluripotency. For the effective use
of stem cells in cell therapy, it is necessary to determine the
pluripotency-associated glycans for isolation from other
differentiated (healthy and tumor) cells.

References
Alisson-Silva F, de Carvalho Rodrigues D, Vairo L, Asensi KD,
Vasconcelos-dos-Santos A, Mantuano NR, Dias WB, Rondinelli
E, Goldenberg RC, Urmenyi TP et al. (2014). Evidences for the
involvement of cell surface glycans in stem cell pluripotency
and differentiation. Glycobiology 24: 458-468.
An HJ, Gip P, Kim J, Wu S, Park KW, McVaugh CT, Schaffer DV,
Bertozzi CR, Lebrilla CB (2012). Extensive determination of
glycan heterogeneity reveals an unusual abundance of high
mannose glycans in enriched plasma membranes of human
embryonic stem cells. Mol Cell Proteomics 11: M111.010660.
André S, Kaltner H, Manning JC, Murphy PV, Gabius HJ (2015).
Lectins: getting familiar with translators of the sugar code.
Molecules 20: 1788-823.
Bernardi A, Cheshev P. Interfering with the sugar code: design and
synthesis of oligosaccharide mimics (2008). Chemistry 14:
7434-7441.
Bieberich E (2014). Synthesis, processing, and function of N-glycans
in N-glycoproteins. Adv Neurobiol 9: 47-70.
Brockhausen I, Narasimhan S, Schachter H (1988) The biosynthesis of
highly branched N-glycans: studies on the sequential pathway
and functional role of N-acetylglucosaminyltransferases I, II,
III, IV, V and VI. Biochimie 70: 1521-1533.
Chen HL, Li CF, Grigorian A, Tian W, Demetriou M (2009). T
cell receptor signaling co-regulates multiple Golgi genes to
enhance N-glycan branching. J Biol Chem 284: 32454-32461.
Chen S, Tan J, Reinhold VN, Spence AM, Schachter H (2002).
UDP-N-acetylglucosamine:alpha-3-D-mannoside
beta1,2-N-acetylglucosaminyltransferase
I
and
UDP-Nacetylglucosamine:alpha-6-D-mannoside
beta-1,2-Nacetylglucosaminyltransferase II in Caenorhabditis elegans.
Biochim Biophys Acta 1573: 271-279.
Cocinero EJ, Çarçabal P (2015). Carbohydrates. Top Curr Chem 364:
299-333.

1056

Cummings RD, Pierce JM (2014). The challenge and promise of
glycomics. Chem Biol 21: 1-15.
D’Agostaro GA, Zingoni A, Moritz RL, Simpson RJ, Schachter H,
Bendiak B (1995). Molecular cloning and expression of cDNA
encoding the rat UDP-N-acetylglucosamine:alpha-6-Dmannoside beta-1,2-N-acetylglucosaminyltransferase II. J Biol
Chem 270: 15211-15221.
Dodla MC, Young A, Venable A, Hasneen K, Rao RR, Machacek DW,
Stice SL (2011). Differing lectin binding profiles among human
embryonic stem cells and derivatives aid in the isolation of
neural progenitor cells. PLoS One 6: e23266.
Draper, JS, Pigott C, Thomson JA, Andrews PW (2002). Surface
antigens of human embryonic stem cells: changes upon
differentiation in culture. J Anat 200: 249-258.
Fujitani N, Furukawa J, Araki K, Fujioka T, Takegawa Y, Piao J,
Nishioka T, Tamura T, Nikaido T, Ito M et al. (2013). Total
cellular glycomics allows characterizing cells and streamlining
the discovery process for cellular biomarkers. P Natl Acad Sci
USA 110: 2105-2110.
Gabius HJ (2000). Biological information transfer beyond the genetic
code: the sugar code. Naturwissenschaften 87: 108-121.
Gabius HJ, André S, Kaltner H, Siebert HC (2002). The sugar code:
functional lectinomics. Biochim Biophys Acta 1572: 165-177.
Hamouda H, Kaup M, Ullah M, Berger M, Sandig V, Tauber
R, Blanchard V (2014). Rapid analysis of cell surface
N-glycosylation from living cells using mass spectrometry. J
Proteome Res 13: 6144-6151.
Hasehira K, Tateno H, Onuma Y, Ito Y, Asashima M, Hirabayashi
J (2012). Structural and quantitative evidence for dynamic
glycome shift on production of induced pluripotent stem cells.
Mol Cell Proteomics 11: 1913-1923.

KARAÇALI / Turk J Biol
Heiskanen A, Hirvonen T, Salo H, Impola U, Olonen A, Laitinen A,
Tiitinen S, Natunen S, Aitio O, Miller-Podraza H et al. (2009).
Glycomics of bone marrow-derived mesenchymal stem cells
can be used to evaluate their cellular differentiation stage.
Glycoconjugate J 26: 367-384.

Liang YJ, Kuo HH, Lin CH, Chen YY, Yang BC, Cheng YY, Yu AL,
Khoo KH, Yu J (2010). Switching of the core structures of
glycosphingolipids from globo- and lacto- to ganglio-series
upon human embryonic stem cell differentiation. P Natl Acad
Sci USA 107: 22564-22569.

Hemmoranta H, Satomaa T, Blomqvist M, Heiskanen A, Aitio O,
Saarinen J, Natunen J, Partanen J, Laine J, Jaatinen T (2007).
N-glycan structures and associated gene expression reflect the
characteristic N-glycosylation pattern of human hematopoietic
stem and progenitor cells. Exp Hematol 35: 1279-1292.

Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken
R, Raychaudhuri S, Ruhaak LR, Lebrilla CB (2015). Glycans
in the immune system and The Altered Glycan Theory of
Autoimmunity: a critical review. J Autoimmun 57: 1-13.

Higashi K, Asano K, Yagi M, Yamada K, Arakawa T, Ehashi T, Mori
T, Sumida K, Kushida M, Ando S et al. (2014). Expression of
the clustered NeuAcα2-3Galβ O-glycan determines the cell
differentiation state of the cells. J Biol Chem 289: 25833-25843.
Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima
M, Urashima T, Oka T, Futai M, Muller WE et al. (2002).
Oligosaccharide specificity of galectins: a search by frontal
affinity chromatography. Biochim Biophys Acta 1572: 232-254.
Hu D, Tateno H, Hirabayashi J (2015). Lectin engineering, a
molecular evolutionary approach to expanding the lectin
utilities. Molecules 20: 7637-7656.
Isaji T, Kariya Y, Xu Q, Fukuda T, Taniguchi N, Gu J (2010).
Functional roles of the bisecting GlcNAc in integrin-mediated
cell adhesion. Method Enzymol 480: 445-459.
Itskovitz-Eldor J (2011). A panel of glycan cell surface markers define
pluripotency state and promote safer cell-based therapies. Cell
Stem Cell 9: 291-292.
Iwaki J, Tateno H, Nishi N, Minamisawa T, Nakamura-Tsuruta S,
Itakura Y, Kominami J, Urashima T, Nakamura T, Hirabayashi
J (2011). The Galβ-(syn)-gauche configuration is required for
galectin-recognition disaccharides. Biochim Biophys Acta
1810: 643-651.
Kaltner H, Gabius HJ (2012). A toolbox of lectins for translating the
sugar code: the galectin network in phylogenesis and tumors.
Histol Histopathol 27: 397-416.
Karaçalı S, İzzetoğlu S, Deveci R (2014). Glycosylation changes
leading to the increase in size on the common core of
N-glycans, required enzymes, and related cancer-associated
proteins. Turk J Biol 38: 754-771.
Kaszuba K, Grzybek M, Orłowski A, Danne R, Róg T, Simons
K, Coskun Ü, Vattulainen I (2015). N-Glycosylation as
determinant of epidermal growth factor receptor conformation
in membranes. P Natl Acad Sci USA 112: 4334-4339.
Kraushaar DC, Dalton S, Wang L (2013). Heparan sulfate: a key
regulator of embryonic stem cell fate. Biol Chem 394: 741-751.
Lanctot PM, Gage FH, Varki AP (2007). The glycans of stem cells.
Curr Opin Chem Biol 11: 373-380.
Liang Y, Eng WS, Colquhoun DR, Dinglasan RR, Graham DR, Mahal
LK (2014). Complex N-linked glycans serve as a determinant
for exosome/microvesicle Cargo recruitment. J Biol Chem 289:
32526-32537.

Miron CE, Petitjean A (2015). Sugar recognition: designing artificial
receptors for applications in biological diagnostics and
imaging. Chembiochem 16: 365-379.
Miwa HE, Song Y, Alvarez R, Cummings RD, Stanley P (2012). The
bisecting GlcNAc in cell growth control and tumor progression.
Glycoconjugate J 29: 609-618.
Murphy PV, André S, Gabius HJ (2013). The third dimension of
reading the sugar code by lectins: design of glycoclusters with
cyclic scaffolds as tools with the aim to define correlations
between spatial presentation and activity. Molecules 18: 40264053.
Nairn AV, Aoki K, de la Rosa M, Porterfield M, Lim JM, Kulik
M, Pierce JM, Wells L, Dalton S, Tiemeyer M et al. (2012).
Regulation of glycan structures in murine embryonic stem
cells: combined transcript profiling of glycan-related genes and
glycan structural analysis. J Biol Chem 287: 37835-37856.
Nakamura M (2008). Stem cell glycobiology. In: Taniguchi N,
Suzuki A, Ito Y, Narimatsu H, Kawasaki T, Hase S, editors.
Experimental Glycoscience: Glycobiology. Tokyo, Japan:
Springer, pp. 262-264.
Nakatsu MN, Deng SX (2013). Enrichment of human corneal
epithelial stem/progenitor cells by magnetic bead sorting using
SSEA4 as a negative marker. Methods Mol Biol 1014: 71-77.
Natunen S, Satomaa T, Pitkänen V, Salo H, Mikkola M, Natunen
J, Otonkoski T, Valmu L (2011). The binding specificity
of the marker antibodies Tra-1-60 and Tra-1-81 reveals a
novel pluripotency-associated type 1 lactosamine epitope.
Glycobiology 21: 1125-1130.
Oliveira MS, Barreto-Filho JB (2015). Placental-derived stem cells:
culture, differentiation and challenges. World J Stem Cells 7:
769-775.
Onuma Y, Tateno H, Hirabayashi J, Ito Y, Asashima M (2013).
rBC2LCN, a new probe for live cell imaging of human
pluripotent stem cells. Biochem Bioph Res Co 431: 524-529.
Pulsipher A, Griffin ME, Stone SE, Hsieh-Wilson LC (2015). Longlived engineering of glycans to direct stem cell fate. Angew
Chem Int Edit 54: 1466-1470.
Quan EM, Kamiya Y, Kamiya D, Denic V, Weibezahn J, Kato K,
Weissman JS (2008). Defining the glycan destruction signal for
endoplasmic reticulum-associated degradation. Mol Cell 32:
870-877.
Rosu-Myles M, McCully J, Fair J, Mehic J, Menendez P, Rodriguez
R, Westwood C (2013). The globoseries glycosphingolipid
SSEA-4 is a marker of bone marrow-derived clonal multipotent
stromal cells in vitro and in vivo. Stem Cells Dev 22: 1387-1397.

1057

KARAÇALI / Turk J Biol
Satomaa T, Heiskanen A, Mikkola M, Olsson C, Blomqvist M,
Tiittanen M, Jaatinen T, Aitio O, Olonen A, Helin J et al.
(2009). The N-glycome of human embryonic stem cells. BMC
Cell Biol 10: 42.
Sheares BT, Carlson DM (1983). Characterization of UDP-galactose:2acetamido-2-deoxy-D-glucose 3 beta-galactosyltransferase
from pig trachea. J Biol Chem 258: 9893-9898.
Sheares BT, Lau JTY, Carlson DM (1982). Biosynthesis of
galacosamine. J Biol Chem 257: 599-602.
Słomińska-Wojewódzka M, Sandvig K (2015). The Role of lectincarbohydrate interactions in the regulation of ER-associated
protein degradation. Molecules 20: 9816-9846.
Smith DF, Cummings RD (2013). Application of microarrays for
deciphering the structure and function of the human glycome.
Mol Cell Proteomics 12: 902-912.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K,
Yamanaka S (2007). Induction of pluripotent stem cells from
adult human fibroblasts by defined factors. Cell 131: 861-872.
Takamatsu S, Korekane H, Ohtsubo K, Oguri S, Park JY, Matsumoto
A, Taniguchi N (2013). N-acetylglucosaminyltransferase
(GnT) assays using fluorescent oligosaccharide acceptor
substrates: GnT-III, IV, V, and IX (GnT-Vb). Methods Mol Biol
1022: 283-298.
Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, Inlay MA,
Ardehali R, Chavez SL, Pera RR et al. (2011). An antibody
against SSEA-5 glycan on human pluripotent stem cells enables
removal of teratoma-forming cells. Nat Biotechnol 29: 829-834.
Taniguchi N, Korekane H (2011). Branched N-glycans and
their implications for cell adhesion, signaling and clinical
applications for cancer biomarkers and in therapeutics. BMB
Rep 44: 772-781.
Tateno H, Toyota M, Saito S, Onuma Y, Ito Y, Hiemori K, Fukumura
M, Matsushima A, Nakanishi M, Ohnuma K et al. (2011).
Glycome diagnosis of human induced pluripotent stem cells
using lectin microarray. J Biol Chem 286: 20345-20353.
Taylor ME, Drickamer K (2011). Introduction to Glycobiology. 3rd
ed. New York, NY, USA: Oxford University Press.
Toyoda M, Yamazaki-Inoue M, Itakura Y, Kuno A, Ogawa T,
Yamada M, Akutsu H, Takahashi Y, Kanzaki S, Narimatsu H
et al. (2011). Lectin microarray analysis of pluripotent and
multipotent stem cells. Genes Cells 16: 1-11.
Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J (2011).
Essentials of Glycobiology. 2nd ed. Cold Spring Harbor, NY,
USA: Cold Spring Harbor Laboratory Press.

1058

Venable A, Mitalipova M, Lyons I, Jones K, Shin S, Pierce M, Stice S
(2005). Lectin binding profiles of SSEA-4 enriched, pluripotent
human embryonic stem cell surfaces. BMC Dev Biol 21: 5-15.
Wang YC, Nakagawa M, Garitaonandia I, Slavin I, Altun G, Lacharite
RM, Nazor KL, Tran HT, Lynch CL, Leonardo TR et al. (2011).
Specific lectin biomarkers for isolation of human pluripotent
stem cells identified through array-based glycomic analysis.
Cell Res 21: 1551-1563.
Wearne KA, Winter HC, Goldstein IJ (2008). Temporal changes in
the carbohydrates expressed on BG01 human embryonic stem
cells during differentiation as embryoid bodies. Glycoconjugate
J 25: 121-136.
Wearne KA, Winter HC, O’Shea K, Goldstein IJ (2006). Use of lectins
for probing differentiated human embryonic stem cells for
carbohydrates. Glycobiology 16: 981-990.
Wright AJ, Andrews PW (2009). Surface marker antigens in the
characterization of human embryonic stem cells. Stem Cell Res
3: 3-11.
Xu O, Isaji T, Lu Y, Gu W, Kondo M, Fukuda T, Du Y, Gu J (2012).
Roles of N-acetylglucosaminyltransferase III in epithelialtomesenchymal transition induced by transforming growth
factor β1 (TGF-β1) in epithelial cell lines. J Biol Chem 287:
16563-16574.
Yanagisawa M (2011). Stem cell glycolipids. Neurochem Res 36:
1623-1635.
Ye Z, Marth JD (2004). N-glycan branching requirement in neuronal
and postnatal viability. Glycobiology 14: 547-558.
Yip

B, Chen SH, Mulder H, Höppener JW, Schachter
H (1997). Organization of the human beta-1,2Nacetylglucosaminyltransferase I gene (MGAT1), which
controls complex and hybrid N-glycan synthesis. Biochem J
321: 465-474.

Zhang WL, Revers L, Pierce M, Schachter H (2000).
Regulation of expression of the human beta-1,2Nacetylglucosaminyltransferase II gene (MGAT2) by Ets
transcription factors. Biochem J 47: 511-518.
Zhong J, Martinez M, Sengupta S, Lee A, Wu X, Chaerkady R,
Chatterjee A, O’Meally RN, Cole RN, Pandey A et al. (2015).
Quantitative phosphoproteomics reveals crosstalk between
phosphorylation and O-GlcNAc in the DNA damage response
pathway. Proteomics 15: 591-607.

